The ARFul truth about melanoma susceptibility genes

Pigment Cell and Melanoma Research

Volumn 21, Issue 5, 2008, Pages 503-504

  Merlino, Glenn ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; CYCLIN DEPENDENT KINASE INHIBITOR 2A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN MDM2; PROTEIN P53; RAS PROTEIN; TRANSCRIPTION FACTOR E2F1; UBIQUITIN PROTEIN LIGASE E3;

DNA SEQUENCE; EXON; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MELANOMA; NONHUMAN; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

ADP-RIBOSYLATION FACTORS; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MELANOMA; MICE; SKIN NEOPLASMS;

EID: 52149121571     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2008.00489.x     Document Type: Short Survey

References (3)

1. Ha, L., Merlino, G. Sviderskaya, E.V. (2008). Melanomagenesis: overcoming the barrier of melanocyte senescence. Cell Cycle. 7, 1944 1948.
2. Larue, L. Beermann, F. (2007). Cutaneous melanoma in genetically modified animals. Pigment Cell Res. 20, 485 497.
3. Saporita, A.J., Maggi, L.B., Jr., Apicelli, A.J. Weber, J.D. (2007). Therapeutic targets in the ARF tumor suppressor pathway. Curr. Med. Chem. 14, 1815 1827.